Ecotoxicology of human pharmaceuticals.
By K. Fent, A. Weston, Daniel Caminada. Aquatic Toxicology, 2006
3,073 citations recorded by the source corpus.
Subfields: Analytical Chemistry, Health, Toxicology and Mutagenesis, Pollution
View Paper: https://www.semanticscholar.org/paper/b8f97e23fb36a2303798beadfe9b87e6a0ee397b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Analytical Chemistry
- C. Pittman
- D. Mohan
- B. Kasprzyk-Hordern
- Richard Dinsdale
- Alan Guwy
- P. Drogui
- Rimeh Daghrir
- M. Sánchez-Polo
In Health, Toxicology and Mutagenesis
In Pollution
- P. Drogui
- Rimeh Daghrir
- M. Wong
- Jin-lin Liu
- B. Kasprzyk-Hordern
- Dan J. Lapworth
- M. Stuart
- Richard Dinsdale
Citations in the corpus
- Sorptive removal of salicylic acid and ibuprofen from aqueous solutions using pine wood fast pyrolysis biochar (2015, background): “Negative effects on humans and animals include the suppression of embryonic cell growth in humans [3], the incapacitation of liver and gills in fish [4], and the inhibition of Gram-positive bacteria [5].”
- Contamination of surface, ground, and drinking water from pharmaceutical production (2009, background): “Low nanograms per liter up to a few micrograms per liter of more than 150 active pharmaceutical ingredients (APIs) have been detected in sewage effluents and surface waters, mainly as a result of excretion with urine and feces and to some extent from inappropriate disposal of unused drugs [1–6].”
- Elimination of pharmaceuticals in sewage treatment plants in Finland. (2007, background): “However, there are not enough data about the subtle changes in the environment caused by continuous discharge of hundreds of pharmacologically active compounds into surface waters (Fent et al., 2006).”
- Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. (2013, background): “Based on the toxicological data and environmental concentration levels, risks of acute toxic effects from these PPCPs are believed to be not likely (Brausch and Rand, 2011; Fent et al., 2006).”
- Activated carbons from agricultural byproducts (pine tree and coconut shell), coal, and carbon nanotubes as adsorbents for removal of sulfamethoxazole from spiked aqueous solutions: Kinetic and thermodynamic studies (2015, background): “…some studies have proved the ability of such chemicals to cause mutagenic and genotoxic effects in aquatic organisms even at low doses; and, in the case of antibiotics, there is also the risk of such pharmaceuticals having adverse effects on humans (Fent et al., 2006; Richard et al., 2014).”
- Carbamazepine (CBZ) induced enzymatic stress in gill, liver and muscle of a common carp, Cyprinus carpio (2012, background): “) have been reported in sewage, rivers and creeks, seawater, surface water, groundwater and drinking water resources throughout the world (Fent et al., 2006; Choi et al., 2008; Rosal et al., 2009).”
- Tetracycline antibiotics in the environment: a review (2013, background): “The long-term and the low-dosed exposures to pharmaceutical products in the environment lead to the adverse impacts to the target organisms including endocrine disruption, chronic toxicity and antibiotic resistance (Andreozzi et al. 2004; Fent et al. 2006).”
- Review of risk from potential emerging contaminants in UK groundwater. (2012, background): “A review by Fent et al. (2006) found that only very little is known about long-term effects of pharmaceuticals to aquatic organisms, in particular with respect to biological targets.”
- The effects of the surface oxidation of activated carbon, the solution pH and the temperature on adsorption of ibuprofen (2013, background): “[2] Fent K, Weston A, Caminada D.”
- Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results. (2009, background): “…classes of drugs (Halling-Sorensen et al., 1998; Jorgensen and Halling-Sorensen 2000; Kümmerer, 2001; Heberer, 2002), the environmental risk assessment strategy (Daughton and Ternes, 1999; Jones et al., 2004; Garric and Ferrari, 2005; Hernando et al., 2005; Fent et al., 2006; Zuccato et al., 2006).”